GB1295814A - - Google Patents

Info

Publication number
GB1295814A
GB1295814A GB1295814DA GB1295814A GB 1295814 A GB1295814 A GB 1295814A GB 1295814D A GB1295814D A GB 1295814DA GB 1295814 A GB1295814 A GB 1295814A
Authority
GB
United Kingdom
Prior art keywords
virus
vaccines
newcastle disease
solution
bayer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GB1295814A publication Critical patent/GB1295814A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/17—Newcastle disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

1295814 Newcastle disease vaccines BAYER AG 19 April 1971 [5 Feb 1970] 21148/71 Heading A5B [Also in Division C6] In a process for the enrichment and purification of Newcastle disease virus, a solution of the virus is mixed with aqueous polyethylene glycol, the resultant mixture centrifuged and the precipitate containing virus separated from the supernatant solution. The virus may be inactivated and used in vaccines.
GB1295814D 1970-02-05 1971-04-19 Expired GB1295814A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19702005117 DE2005117A1 (en) 1970-02-05 1970-02-05 Process for the enrichment and purification of solutions of the Newcastle Disease Virus

Publications (1)

Publication Number Publication Date
GB1295814A true GB1295814A (en) 1972-11-08

Family

ID=5761435

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1295814D Expired GB1295814A (en) 1970-02-05 1971-04-19

Country Status (6)

Country Link
BE (1) BE762581A (en)
DE (1) DE2005117A1 (en)
FR (1) FR2078246A5 (en)
GB (1) GB1295814A (en)
NL (1) NL7101370A (en)
ZA (1) ZA71732B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7216091A (en) * 1971-12-03 1973-06-05

Also Published As

Publication number Publication date
ZA71732B (en) 1971-10-27
DE2005117A1 (en) 1971-08-19
BE762581A (en) 1971-08-05
NL7101370A (en) 1971-08-09
FR2078246A5 (en) 1971-11-05

Similar Documents

Publication Publication Date Title
GB1356427A (en) Process for separating glucagon from pancreatic extracts
AU4700072A (en) New cyclic urea derivatives and salts thereof process forthe production thereof and pharmaceutical preparations containing thesame
GB1295814A (en)
CA991193A (en) Derivatives of pyrroleacetic acids, salts thereof and their process of preparation
CA962059A (en) Composition and process for treating aqueous alkaline fuel
CA958641A (en) Equine strangles vaccine and method of preparing and using the same
CA962593A (en) Highly attenuated newcastle disease virus vaccine and production thereof
CA1021261A (en) Herpes simplex type 2 virus vaccine and method of production and use
CA953724A (en) Derivatives of isocyanuric acid and processes for preparing the same
GB1416544A (en) Immunizing agents for bacterial infections
GB1155793A (en) Process for the Recovery and Purification of Lysozyme
GB1302202A (en)
ES403128A1 (en) Preparation and separation of 1,5- and 1,8-dihydroxyanthraquinone
GB1384840A (en) Process for preparing bisphenol-a
GB1389834A (en) Treatment of textile materials
AU456693B2 (en) Improvements; in virus vaccines
YU36600B (en) Process for the elimination and recuperation of precipitation agents such as lignosulfates, laurylsulfate, glyceryl trisulfate and dodecyl benzosulfonic acid from a proteinic matter comprising precipitate
GB1250417A (en)
ZA712711B (en) Process for the preparation of alive varicella virus useful as an antigen in a vaccine
AU2793971A (en) Marek's disease inactivated vaccine and process for preparing the same
GB1256020A (en) Enzyme purification
GR25079B (en) METHOD FOR THE PREPARATION OF COMPOSITIONS OF THE CARVAZOLIC SERIES.
GB1290468A (en)
Brown et al. 4-Phenoxyflavan-3-ols
CA884330A (en) Water-insoluble benzoxanthene-dicarboxylic acid imide dyestuffs and process for preparing them

Legal Events

Date Code Title Description
CSNS Application of which complete specification have been accepted and published, but patent is not sealed